Back

Hypertrophic Cardiomyopathy -- The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family Screening

2025-04-21 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundHypertrophic cardiomyopathy (HCM) is a complex disease with variable clinical presentation and familial impact. Age at diagnosis may influence phenotypic expression, but it is unclear if age also affects clinical outcomes, genetic findings, and yield of family screening. MethodsRetrospective cohort study of families screened for HCM in Eastern Denmark (2006-2023). Probands were analyzed by age at diagnosis both continuously and in quartiles: 18-45, 46-56, 57-65, and >65 years. Result...

Predicted journal destinations